Find similar content

Source channel @githubtrending · Post #14981 · Jul 21

#typescript#bun#conversion#convert#converter#document_conversion#elysia#file_conversion#file_converter#hacktoberfest#pdf_converter#self_hosted#tailwindcss#typescript ConvertX is a self-hosted online file converter that supports over a thousand file formats, including images, videos, documents, e-books, and 3D assets. It lets you convert multiple files at once, offers password protection, and supports multiple user accounts for privacy. You can run it easily using Docker, making it simple to set up on your own server. This means your files stay private since conversions happen locally without sending data to external servers. It uses powerful open-source tools like FFmpeg and ImageMagick, giving you a versatile and secure way to handle all your file conversion needs in one place[1][2]. https://github.com/C4illin/ConvertX

Hashtags

#typescript #bun #conversion #convert #converter #document_conversion #elysia #file_conversion #file_converter #hacktoberfest #pdf_converter #self_hosted #tailwindcss

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment